Bioservo Technologies

On May 10 at 13:45, Bioservo's CEO, Petter Bäckgren, will present the latest news from the company at Redeye Medtech Event. The presentation will be broadcast live and can be followed on https://www.redeye.se/events/870864/redeye-medtech-event where the recording and presentations will also be available afterward.

Bioservo is a world-leading company in portable, muscle-strengthening systems for the hands that is entering an exciting expansion phase. During the first quarter, the company began delivering a completely new generation of Carbonhand to patients with impaired hand function and distributors in Europe and Australia, and in the industrial segment, interest in Ironhand is growing after, for example, the foundry group Waupaca introduced the systems at several production facilities.

In April, the company made Carbonhand available as a medical device in the US and has begun work on establishing a partner network to commercialize the product in the US market, which represents over 40% of the market for medical devices.

This and more will be presented at the Redey Medtech Event on May 10th.

For more information, please contact,
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10
petter.backgren@bioservo.com

Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: +468 21 17 10
mikael.wester@bioservo.com

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world-leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health of workers and to improve the quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB is the company’s Certified Adviser on Nasdaq First North.
For more information, please visit www.bioservo.com